Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...
eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...
Along with fellow LNP Alliance members, NOF Corporation and Neosome Life Sciences, Phosphorex is hosting a free, one-hour virtual discussion entitled, "Streamline Targeted LNP Development to Improve ...
CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported recent ...
MADISON, Wis., April 28, 2026--(BUSINESS WIRE)--A new agreement between Promega Corporation and the RNA & Formulation Core at the University of British Columbia will enable the facility to manufacture ...
BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service agreement under which BIOVECTRA will accept, on a non-exclusive basis, Acuitas’ ...
AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
Recent advances in mRNA and lipid nanoparticle (LNP) technology have allowed for the development of new vaccines and therapeutics, holding great promise for gene therapy. In 2018, patisiran (Onpattro) ...
Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is revolutionizing lipid nanoparticle (LNP) analysis with the launch of the ONI Application Kitâ„¢: LNP Profiler, the first and only ...
COLCHESTER, Vt.--(BUSINESS WIRE)--Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of ...
Authorization expands academic and industry researcher access for LNP delivery optimization, mRNA vaccine development and gene therapy research A new agreement between Promega Corporation and the RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results